Delta Wave on ECG
A delta wave is a slurred upstroke at the beginning of the QRS complex representing ventricular pre-excitation through an accessory pathway, most commonly seen in Wolff-Parkinson-White (WPW) syndrome, and requires risk stratification with electrophysiology study in symptomatic patients or those with high-risk features. 1
ECG Characteristics
The delta wave appears as part of a constellation of findings in ventricular pre-excitation 1:
- Short PR interval (<0.12 seconds)
- Slurred initial QRS upstroke (the delta wave itself)
- Widened QRS complex (>0.12 seconds total duration)
- Secondary ST-T wave changes that are discordant (opposite direction) to the delta wave and QRS 2
The delta wave reflects early ventricular activation as the electrical impulse bypasses the AV node through an accessory pathway, creating direct atrial-to-ventricular conduction 1.
Clinical Significance
Risk Stratification Framework
Symptomatic patients with documented SVT = WPW syndrome (not just pre-excitation pattern) 1. The critical distinction:
- Asymptomatic pre-excitation: Delta wave present but no arrhythmia symptoms
- WPW syndrome: Delta wave PLUS documented SVT or consistent symptoms 1
High-Risk Features Requiring Urgent Attention
Syncope in WPW patients warrants serious evaluation 1, though it doesn't automatically predict sudden cardiac death risk. The most dangerous scenario is atrial fibrillation with rapid ventricular response through the accessory pathway, which can degenerate to ventricular fibrillation 2, 3.
ECG clues to AF in WPW 3:
- Irregular rhythm with very rapid rate
- Visible delta waves during the arrhythmia
- Wide, bizarre QRS complexes
Prevalence and Natural History
Occurs in 0.1-3% of the general population 2. Most patients remain asymptomatic lifelong, but when symptoms occur, they stem from tachyarrhythmias including 2:
- Paroxysmal SVT (narrow or wide complex)
- Atrial fibrillation
- Atrial flutter
- Ventricular fibrillation (rare but catastrophic)
Management Algorithm
Step 1: Identify Pattern Type
Intermittent pre-excitation still carries risk and warrants electrophysiology study to assess anterograde conduction properties 4. Don't be falsely reassured by intermittent findings.
Step 2: Symptom Assessment
- Symptomatic (palpitations, syncope, documented arrhythmia): Proceed directly to electrophysiology study 5
- Asymptomatic: Electrophysiology study recommended if pathway demonstrates rapid anterograde conduction capability 5
Step 3: Electrophysiology Study Findings
The study characterizes 5:
- Accessory pathway location
- Refractory period (APERP <240 ms = higher risk) 6
- Inducibility of arrhythmias
If rapid anterograde conduction is present: immediate radiofrequency ablation recommended in both symptomatic AND asymptomatic patients 5. This represents definitive management.
Step 4: Acute Arrhythmia Management
Critical pitfall: In stable AF with WPW, avoid AV nodal blocking agents (adenosine, beta-blockers, calcium channel blockers, digoxin) as these can accelerate conduction through the accessory pathway 3.
Appropriate acute treatments 3:
- Stable patients: Procainamide or ibutilide
- Unstable patients: Immediate electrical cardioversion
Important Caveats
Mimicry on ECG
Delta waves can simulate 7:
- Ischemic heart disease
- Ventricular hypertrophy
- Bundle branch block
Always consider WPW in young patients with these ECG patterns, especially with palpitation history.
Special Pathway Types
Fasciculoventricular pathways produce delta waves but represent a benign variant with fixed short HV interval that doesn't change with pacing—these are NOT ablatable and require no intervention 8. Distinguish these during electrophysiology study.
Genetic Considerations
In patients with delta wave plus cardiomyopathy (especially hypertrophic pattern), consider PRKAG2 mutation causing glycogen-storage cardiomyopathy—this requires different management focused on heart failure and progressive conduction disease rather than pathway ablation 8.